Helius Medical Technologies, Inc. provided revenue guidance for the first quarter of 2022. For the period, the company expects revenue to range from $150,000 to $170,000 and quarterly revenue to increase sequentially each quarter throughout the year as the U.S. commercialization of PoNS develops.
Helius Medical Technologies, Inc.
Equities
HSDT
US42328V8019
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | -1.32% | -7.98% | -81.34% |
May. 13 | Transcript : Helius Medical Technologies, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
May. 13 | Earnings Flash (HSDT) HELIUS MEDICAL TECHNOLOGIES Posts Q1 Revenue $135,000 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.34% | 4.09M | |
+11.89% | 228B | |
+14.48% | 196B | |
+17.74% | 141B | |
+28.38% | 110B | |
+0.53% | 65.88B | |
+16.59% | 54.3B | |
+6.33% | 52.39B | |
+11.18% | 45.22B | |
+5.24% | 37.12B |
- Stock Market
- Equities
- HSDT Stock
- News Helius Medical Technologies, Inc.
- Helius Medical Technologies, Inc. Provides Revenue Guidance for the First Quarter of 2022